Health care coverage, from private insurance to employer-provided health care to public programs like Medicare and Medicaid, can have various impacts on people’s use of health care and, ultimately, their health and well-being.
At this early stage of social determinant of health incorporation, many states are targeting their programming, particularly screening and care management/coordination, towards high-risk populations, such as beneficiaries in substance use disorder treatment or those with significant behavioral health needs, children with complex care needs, beneficiaries living with HIV, and individuals with multiple comorbidities.
The Evidence-Informed State Health Policy Institute (ESHPI) developed a COVID-19-related research agenda exploring how Medicaid can examine the long-term impact on beneficiaries and the program.
With the recent expiration of the federal eviction moratorium and the heightened focus on social determinants of health during the COVID-19 pandemic, this new cross-state analysis of permanent supportive housing programs is timelier than ever.
With funding from the National Institutes on Drug Abuse (NIDA), Medicaid Outcomes Distributed Research Network (MODRN) members and AcademyHealth conducted key informant interviews with nine states to describe the roles that Medicaid programs have taken to address the opioid epidemic and their policy and operational decisions.
Lack of data regarding dual-eligible individuals has long hindered the development of effective policy solutions and care improvement. AcademyHealth organizational member Arnold Ventures highlights new resources to help the research community strengthen and expand evidence at a critical time in the policy debate.
As lead clinicians for their states with responsibility for overseeing clinical care and stewardship of resources, Medicaid Medical Directors share their perspectives on clinical matters related to the FDA’s Accelerated Approval Program.
Leveraging data from AcademyHealth’s Medicaid Outcomes Distributed Research Network (MODRN), new research finds substantial improvements in use of medications for OUD. Improved understanding of the factors driving this increase is crucial to closing remaining treatment gaps.
As partners in the Going Below The Surface Forum, AcademyHealth and the National Pharmaceutical Council (NPC) consider the drivers of health spending in the U.S. through salons focused on challenging questions. Today’s post takes a closer look at strategies to reduce costs via employer-sponsored health benefits.
This month’s “Read on Washington,” available only to AcademyHealth members, includes updates on appropriations bills, negotiations to expand Medicare, an executive order to combat drug and medical prices, VA mandates for COVID-19 vaccines, and more.
A new study published in HSR, an official journal of AcademyHealth, found that urgent care centers reduce costly emergency department (ED) visits, especially in areas with long ED wait times as well as among Medicaid enrollees and the uninsured.
